Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 4, Human | 4 | 2021 | 43 | 2.420 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2021 | 994 | 1.390 |
Why?
|
| Glomerulonephritis | 4 | 2017 | 16 | 1.330 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2021 | 28 | 1.280 |
Why?
|
| Necrosis | 4 | 2014 | 85 | 0.900 |
Why?
|
| Estradiol | 3 | 2015 | 176 | 0.880 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2015 | 22 | 0.820 |
Why?
|
| Apoptosis | 4 | 2014 | 780 | 0.740 |
Why?
|
| Antibodies, Viral | 2 | 2019 | 80 | 0.740 |
Why?
|
| Kidney | 4 | 2016 | 289 | 0.650 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2019 | 20 | 0.620 |
Why?
|
| Herpesviridae Infections | 1 | 2019 | 17 | 0.610 |
Why?
|
| Antigens, Viral | 1 | 2019 | 24 | 0.610 |
Why?
|
| Neutrophils | 4 | 2009 | 185 | 0.600 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 89 | 0.570 |
Why?
|
| Viral Proteins | 1 | 2018 | 63 | 0.560 |
Why?
|
| Interleukin-10 | 1 | 2018 | 74 | 0.560 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2017 | 2 | 0.550 |
Why?
|
| Connective Tissue Diseases | 1 | 2017 | 13 | 0.550 |
Why?
|
| Autoimmunity | 1 | 2019 | 158 | 0.550 |
Why?
|
| Scleroderma, Systemic | 1 | 2017 | 29 | 0.540 |
Why?
|
| Exocytosis | 3 | 2009 | 13 | 0.540 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 128 | 0.540 |
Why?
|
| Monocytes | 1 | 2018 | 135 | 0.530 |
Why?
|
| Sjogren's Syndrome | 1 | 2021 | 274 | 0.530 |
Why?
|
| Peptides | 1 | 2019 | 296 | 0.520 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 134 | 0.500 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2016 | 2 | 0.490 |
Why?
|
| HMGB1 Protein | 1 | 2016 | 5 | 0.490 |
Why?
|
| Lupus Nephritis | 2 | 2017 | 103 | 0.490 |
Why?
|
| Autoantigens | 2 | 2019 | 212 | 0.460 |
Why?
|
| Mesangial Cells | 1 | 2015 | 9 | 0.460 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 23 | 0.460 |
Why?
|
| Estrogens | 1 | 2015 | 56 | 0.450 |
Why?
|
| Actins | 3 | 2009 | 99 | 0.390 |
Why?
|
| RNA, Messenger | 1 | 2015 | 668 | 0.390 |
Why?
|
| Signal Transduction | 4 | 2017 | 1469 | 0.380 |
Why?
|
| Deoxyribonucleases | 1 | 2011 | 6 | 0.360 |
Why?
|
| Secretory Vesicles | 3 | 2009 | 12 | 0.350 |
Why?
|
| Antibodies, Antinuclear | 1 | 2011 | 183 | 0.330 |
Why?
|
| Mice | 9 | 2019 | 4808 | 0.320 |
Why?
|
| Animals | 10 | 2019 | 10699 | 0.290 |
Why?
|
| Cell Membrane | 2 | 2008 | 268 | 0.290 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 1508 | 0.280 |
Why?
|
| Humans | 13 | 2021 | 28884 | 0.270 |
Why?
|
| Chemotaxis | 1 | 2007 | 28 | 0.260 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 38 | 0.260 |
Why?
|
| Cytoskeleton | 1 | 2007 | 45 | 0.250 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 95 | 0.250 |
Why?
|
| Female | 7 | 2019 | 15634 | 0.240 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 123 | 0.240 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 2 | 2015 | 8 | 0.220 |
Why?
|
| Inflammation | 1 | 2009 | 668 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 257 | 0.210 |
Why?
|
| Male | 6 | 2019 | 13934 | 0.210 |
Why?
|
| Biomarkers | 2 | 2017 | 777 | 0.200 |
Why?
|
| Antigens, CD | 2 | 2018 | 140 | 0.200 |
Why?
|
| Sex Factors | 3 | 2017 | 467 | 0.190 |
Why?
|
| Middle Aged | 3 | 2019 | 7416 | 0.190 |
Why?
|
| Adult | 3 | 2019 | 8030 | 0.180 |
Why?
|
| Autoantibodies | 3 | 2017 | 481 | 0.150 |
Why?
|
| Cross Reactions | 1 | 2019 | 74 | 0.150 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 48 | 0.150 |
Why?
|
| Thiazolidines | 3 | 2009 | 6 | 0.150 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 3 | 2009 | 10 | 0.150 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2009 | 52 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 14 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 278 | 0.150 |
Why?
|
| Epitopes | 1 | 2019 | 185 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 97 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 114 | 0.140 |
Why?
|
| Transcription Factor RelA | 2 | 2015 | 22 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 27 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2019 | 739 | 0.130 |
Why?
|
| Gene Expression | 2 | 2017 | 417 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2017 | 82 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1032 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 19 | 0.120 |
Why?
|
| Urinalysis | 1 | 2016 | 11 | 0.120 |
Why?
|
| Creatinine | 1 | 2016 | 59 | 0.120 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2013 | 25 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2017 | 216 | 0.120 |
Why?
|
| Cyclophilins | 1 | 2015 | 1 | 0.120 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 2015 | 40 | 0.120 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 7 | 0.120 |
Why?
|
| Avian Proteins | 1 | 2015 | 5 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 25 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1022 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2015 | 34 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2015 | 72 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 80 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 328 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2014 | 22 | 0.110 |
Why?
|
| Mitochondria | 2 | 2015 | 408 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 465 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 247 | 0.110 |
Why?
|
| Risk Factors | 1 | 2019 | 2127 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 169 | 0.100 |
Why?
|
| Disease Progression | 2 | 2017 | 477 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2012 | 27 | 0.090 |
Why?
|
| Interferons | 1 | 2012 | 70 | 0.090 |
Why?
|
| Cytokines | 1 | 2014 | 451 | 0.090 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2011 | 3 | 0.090 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 6 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 52 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 37 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2011 | 138 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2012 | 141 | 0.080 |
Why?
|
| Receptors, Complement 3b | 2 | 2009 | 7 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 251 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2011 | 292 | 0.080 |
Why?
|
| Neutrophil Activation | 1 | 2009 | 6 | 0.080 |
Why?
|
| Clathrin | 1 | 2009 | 20 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 676 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 634 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 285 | 0.070 |
Why?
|
| Endocytosis | 1 | 2009 | 96 | 0.070 |
Why?
|
| Microtubules | 1 | 2009 | 90 | 0.070 |
Why?
|
| Survival Rate | 1 | 2009 | 432 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 166 | 0.070 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2007 | 6 | 0.070 |
Why?
|
| Lactoferrin | 1 | 2007 | 3 | 0.070 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 13 | 0.070 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2007 | 13 | 0.060 |
Why?
|
| Gelatinases | 1 | 2007 | 14 | 0.060 |
Why?
|
| Cytochalasin D | 1 | 2007 | 10 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 45 | 0.060 |
Why?
|
| Tetraspanin 30 | 1 | 2007 | 7 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 50 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 242 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 69 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 109 | 0.060 |
Why?
|
| Aged | 1 | 2016 | 5599 | 0.060 |
Why?
|
| Kinetics | 1 | 2007 | 553 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2007 | 585 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 612 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 485 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2015 | 30 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 874 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 292 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2017 | 19 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 32 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 82 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 74 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 156 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 152 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2015 | 20 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 465 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 119 | 0.030 |
Why?
|
| ORAI1 Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 137 | 0.030 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2015 | 8 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 212 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 62 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 202 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 80 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 355 | 0.030 |
Why?
|
| Calcium | 1 | 2015 | 243 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 700 | 0.020 |
Why?
|
| Mice, Inbred NZB | 1 | 2012 | 14 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 17 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 36 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 68 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 191 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 515 | 0.020 |
Why?
|
| Cadaverine | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ionomycin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Chlorpromazine | 1 | 2009 | 3 | 0.020 |
Why?
|
| Transferrin | 1 | 2009 | 10 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 22 | 0.020 |
Why?
|
| Sucrose | 1 | 2009 | 27 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 17 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2008 | 15 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 135 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1613 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 166 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 117 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1658 | 0.020 |
Why?
|
| Proteomics | 1 | 2008 | 197 | 0.020 |
Why?
|